C81.0A
BillableNodular lymphocyte predominant Hodgkin lymphoma, in remission
HCC Category Mapping
What This Code Means
Nodular lymphocyte predominant Hodgkin lymphoma that is currently in remission, meaning there is no evidence of active disease.
Coding Tips
- •Use this code only when remission status is explicitly documented by the physician
- •This code can be used with any site; the 'A' suffix indicates remission status
Clinical Significance
Nodular lymphocyte predominant Hodgkin lymphoma in remission indicates that previously diagnosed NLPHL shows no evidence of active disease. NLPHL has a high remission rate but a characteristic pattern of late relapses even 10-15 years after initial treatment. Continued surveillance is essential, and the remission designation still captures the diagnosis for risk adjustment purposes, reflecting the ongoing monitoring and potential for recurrence these patients require.
Documentation Requirements
- ✓Physician documentation explicitly stating the patient is in remission
- ✓Imaging (PET/CT) confirming no evidence of active disease (Deauville score 1-3)
- ✓Date remission was achieved
- ✓Whether this is complete remission or partial remission
- ✓Surveillance schedule documented
- ✓Assessment for late effects of treatment